Rivernorth Capital Management’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Rivernorth Capital Management’s Portfolio CDIOW Stock Details CDIOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-39,830	Closed	-$6.77K	–	467
2023 Q4	$6.77K	Sell	39,830 -9,269	-19%	-$921	﹤0.01%	348
2023 Q3	$1.96K	Hold	49,099	–	–	﹤0.01%	498
2023 Q2	$9.33K	Sell	49,099 -900	-2%	-$165	﹤0.01%	420
2023 Q1	$16K	Hold	49,999	–	–	﹤0.01%	446
2022 Q4	$2.5K	Hold	49,999	–	–	﹤0.01%	640
2022 Q3	$8K	Hold	49,999	–	–	﹤0.01%	696
2022 Q2	$6K	Hold	49,999	–	–	﹤0.01%	705
2022 Q1	$10K	Buy	+49,999	New	+$11.9K	﹤0.01%	751

Other funds holding CDIOW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Rivernorth Capital Management's CDIOW Position: Q1 2024 in Review

Rivernorth Capital Management sold out of Cardio Diagnostics Holdings Inc Warrant (CDIOW) in Q1 2024, closing a stake of 39,830 shares — an estimated $6.77K sold.

Rivernorth Capital Management first reported a position in CDIOW in Q1 2022 and held it in 8 quarters. The position peaked at $16K in Q1 2023. 12 funds tracked by Wall St. Rank hold CDIOW as of Q1 2024.

Rivernorth Capital Management reported no remaining Cardio Diagnostics Holdings Inc Warrant position as of Q1 2024 after selling out during the quarter.
Rivernorth Capital Management sold 39,830 Cardio Diagnostics Holdings Inc Warrant shares in Q1 2024, an estimated $6.77K.
Rivernorth Capital Management first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and held it in 8 quarters.
Rivernorth Capital Management's Cardio Diagnostics Holdings Inc Warrant position peaked at $16K in Q1 2023.
12 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q1 2024.

Based on Rivernorth Capital Management's 13F filing for Q1 2024, filed 15 May 2024.